m+Medelevator.RU
← Поиск публикаций
Journal of medical case reports · 2026

Myxoid liposarcoma of sigmoid mesocolon: a case report and review of the literature.

СтатьяКлинический случайОбзорНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Hamed Raed R, Abbas Abbas W, Abu-Hilal Lila H, Abulehia Ayah, Abu Zaydeh Omar H, Abukeshek Tawfiq, Bakri Izzedin A, Jaber Bashar

Аннотация

BACKGROUND: Liposarcoma is a malignant mesenchymal tumor most commonly arising in the extremities and retroperitoneum. Involvement of the mesentery is rare, and primary liposarcoma of the large bowel mesentery has been reported fewer than 15 times in the English literature. Among its histological subtypes, myxoid liposarcoma is exceptionally rare in this location, with only four previous cases described. Owing to its rarity, there are no standardized management protocols, although wide surgical excision with negative margins remains the mainstay of treatment.

CASE PRESENTATION: We report a 73 year-old Arab male with hypertension and ischemic heart disease who presented with painless abdominal swelling and anorexia. Imaging revealed a large left mesocolon mass, and a left hemicolectomy with colosigmoid anastomosis achieved R0 margins. Histopathology confirmed primary myxoid liposarcoma of the mesocolon. The patient had an uneventful recovery and remains disease-free 1 year after surgery.

CONCLUSION: Primary myxoid liposarcoma of the mesocolon is extremely rare, with this case representing only the fifth reported instance. Review of the literature indicates that complete surgical resection is the cornerstone of management, while the role of adjuvant radiotherapy or chemotherapy remains controversial. Reporting additional cases is essential to improve understanding, refine prognostic assessment, and guide the development of evidence-based treatment strategies.

Предметные рубрики MeSH

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты